PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients
Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related ...
Dec 02, 2009
4 / 5 (1)
0
